Investors

Insider Transactions

Date Name Title Type Shares Traded Sorted Ascending Price Range
Dec 21, 2009 mccorkle douglas s Officer Option Execute 2,456 8.50
Dec 20, 2011 goldberg murray a Officer Option Execute 2,500 11.64
Aug 20, 2008 goldstein joseph l Director Disposition (Non Open Market) 2,500 n/a
May 31, 2013 ryan arthur f Director Sell 2,500 249.45 - 249.58
Nov 13, 2009 sing george l Director Buy 2,500 18.68 - 18.72
May 18, 2010 sing george l Director Buy 2,500 28.64
Jan 26, 2011 roberts william Officer Automatic Sell 2,693 34.49
Mar 6, 2014 brown michael s Director Acquisition (Non Open Market) 2,700 n/a
Apr 11, 2013 mccorkle douglas s Officer Automatic Sell 2,746 204.57
Feb 11, 2011 goldstein joseph l Director Automatic Sell 2,761 36.66
Dec 18, 2012 mccorkle douglas s Officer Automatic Sell 2,784 177.46 - 180.36
Dec 17, 2010 brown michael s Director Automatic Sell 2,897 32.44
Oct 26, 2012 brown michael s Director Sell 3,000 154.69
Aug 6, 2012 brown michael s Director Sell 3,000 136.29
Aug 6, 2012 brown michael s Director Option Execute 3,000 23.84
Oct 26, 2012 brown michael s Director Option Execute 3,000 23.84
Aug 11, 2008 goldstein joseph l Director Acquisition (Non Open Market) 3,000 n/a
Feb 20, 2014 mccorkle douglas s Officer Option Execute 3,000 21.25
May 23, 2013 ryan arthur f Director Disposition (Non Open Market) 3,000 n/a
Mar 10, 2011 brown michael s Director Automatic Sell 3,094 39.09
Showing 81-100 of 790 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)